Purchase Order HHSN272201200891P
- Not listed
- This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company, to provide specialized scientific instruments, reagents, and services to support the NIH's biomedical research and cell therapy development programs. The $5,420 firm fixed-price purchase order has a period of performance through September 2023. Miltenyi Biotec holds a significant $2.3 million indefinite delivery contract (IDC) with the NIH Clinical...
- This $4,884 firm fixed price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is not associated with a set-aside. Under this award, Miltenyi Biotec will supply the NIH Clinical Center with proprietary CliniMACS cell isolation reagents and consumables required for Good...
- This $3,742.63 firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract supports the delivery and installation of Miltenyi's proprietary CliniMACS cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as associated reagents and consumables. This award is a standalone...
- The federal contract award is for a service agreement with Miltenyi Biotec, Inc., a global biotechnology company that specializes in scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract, valued at $10,180.00, is a firm fixed-price purchase order awarded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a civilian agency within the National Institutes of Health (NIH). The contract runs from August 1, 2024, to...
- This is a $312,065 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company specializing in cell therapy products and instruments. The contract provides for the delivery and installation of specialized laboratory equipment such as CliniMACS Prodigy cell processing systems, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as proprietary cell isolation reagents and...
- This federal contract award to Miltenyi Biotec, Inc. is for the supply of laboratory equipment, including flow cytometers, cell sorters, tissue dissociators, and associated reagents and consumables. The $4,881 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to...
- This is a firm fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency, to Miltenyi Biotec, Inc. in the amount of $24,646.00. The contract is for the delivery of Miltenyi's GentleMACS instruments and associated products, which are used for cell separation, analysis, and processing in biomedical research. Miltenyi Biotec is a global biotechnology company that provides specialized scientific equipment, reagents, and...
- This is a federal contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract award, valued at $20,493.00, is a firm fixed-price purchase order to supply Miltenyi Biotec's proprietary CliniMACS cell isolation reagents, consumables, and related services to support the NIH's cell therapy manufacturing capabilities. This single-award...
- This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The $7,009 contract supports the delivery and installation of Miltenyi Biotec's CliniMACS Prodigy cell processing system, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as...
- This $142,174 firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract is for the supply of CliniMACS Prodigy Essential Service Units to support the NIH Clinical Center's cell therapy manufacturing capabilities. This award is part of a larger $2.3 million indefinite delivery contract (IDC) that Miltenyi...
This federal contract award to Miltenyi Biotec, Inc. is for the delivery of specialized laboratory equipment, reagents, and consumables to the National Institutes of Health (NIH) Clinical Center. The $5,406.00 firm-fixed-price purchase order includes products such as the GentleMACS Tissue Dissociation Kit and GentleMACS C Tubes, provided at no additional cost to the government. The award is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds with the NIH Clinical Center. This IDC, awarded in June 2023, ensures the availability of FDA-approved, clinical-grade reagents and supplies compatible with the NIH's existing CliniMACS instrumentation, which is used for the production of investigational cell therapy products in NIH clinical trials. The contract has no set-aside designation. As a global biotechnology company, Miltenyi Biotec has extensive experience as a prime contractor for various federal agencies, including the NIH, Department of Veterans Affairs, and Department of Defense, providing specialized laboratory equipment, reagents, and technical support services to support biomedical research and cell therapy development.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/21/12 |